NLOCF Research Acceleration Fund
On February 21, 2016, the Norma Livingston Ovarian Cancer Foundation presented a check for $110,555 to fund two projects at the University of Alabama at Birmingham’s Division of Gynecologic Oncology.
These funds will support Dr. Rebecca Arend’s research pertaining to why women with ovarian cancer become resistant to chemotherapy, why they recur, and how the medical profession can prevent this from happening. Advances in surgery and chemotherapy have improved patient responses and increased their time in remission, but cure rates have not significantly changed in the last 20 years and the majority of patients eventually recur. We are optimistic that this research will impact the lives of women with ovarian cancer.
These funds will also support the NORMA LIVINGSTON OVARIAN CANCER FOUNDATION TELEMEDICINE GENETICS CLINIC. This innovative pilot program will help reduce the risk of women getting ovarian cancer by offering genetic testing and counseling services to women with a personal or family history of ovarian, breast cancer, and endometrial cancer. A key component of this service is expert genetic counseling from an experienced, trained genetic counselor, especially one with experience in hereditary cancers. Access to this type of service can sometimes be difficult due to travel, work, and personal constraints. Through the NLOCF Telemedicine Genetics Clinic more women will have access to this service. Theoretically, this clinic has the benefit of providing access to the entire State of Alabama, the Southeast region, and certain, under-served pockets in the United States.